Search scope:
排序: Display mode:
A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy
Xiaolong Wei,Chunfa Chen,Didi Xi,Jinwen Bai,Wenhe Huang,Luoxiang Rong,Mingyao Wu,Guojun Zhang
Frontiers of Medicine 2015, Volume 9, Issue 1, Pages 112-116 doi: 10.1007/s11684-014-0345-z
Keywords: neuroendocrine carcinoma neo-adjuvant therapy breast
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 93-104 doi: 10.1007/s11684-021-0892-z
Keywords: chemotherapy cervical cancer lymph node metastasis concurrent chemoradiotherapy quality of life
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma
Wei Zhang, Bixiang Zhang, Xiao-ping Chen
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 155-169 doi: 10.1007/s11684-021-0848-3
Keywords: hepatocellular carcinoma adjuvant treatment hepatic resection recurrence
Hudan Pan, Yanfang Zheng, Zhongqiu Liu, Zhongwen Yuan, Rutong Ren, Hua Zhou, Ying Xie, Liang Liu
Frontiers of Medicine 2019, Volume 13, Issue 5, Pages 564-574 doi: 10.1007/s11684-018-0676-2
Keywords: rheumatoid arthritis traditional Chinese medicine pharmacological mechanism metabolism adjuvant-induced
Frontiers of Chemical Science and Engineering 2022, Volume 16, Issue 6, Pages 973-984 doi: 10.1007/s11705-021-2123-1
Keywords: pickering emulsion vaccine adjuvant alum-stabilised emulsion oleic to linoleic acid ratio stability
Influence of the adjuvant therapy on the survival of patients with stage II pancreatic carcinoma
Xi-Yan WANG, Hai-Jun LI, Dong YAN, Hao WEN, Shu-Yong PENG,
Frontiers of Medicine 2010, Volume 4, Issue 4, Pages 430-435 doi: 10.1007/s11684-010-0700-7
Keywords: pancreatic neoplasms neoadjuvant therapy survival
Dual Effects of Feed-Additive-Derived Chelerythrine in Combating Mobile Colistin Resistance Article
Huangwei Song,Xueyang Wang,Muchen Zhang,Zhiyu Zou,Siyuan Yang,Tian Yi,Jianfeng Wang,Dejun Liu,Yingbo Shen,Chongshan Dai,Zhihai Liu,Timothy R. Walsh,Jianzhong Shen,Congming Wu,Yang Wang,
Engineering 2024, Volume 32, Issue 1, Pages 163-173 doi: 10.1016/j.eng.2023.06.012
The emergence and spread of the mobile colistin-resistance gene, mcr-1, and its variants pose a challenge to the use of colistin, a last-resort antibiotic used to treat severe infections caused by extensively drug-resistant (XDR) Gram-negative pathogens. Antibiotic adjuvants are a promising strategy to enhance the efficacy of colistin against colistin-resistant pathogens; however, few studies have considered the effects of adjuvants on limiting resistance-gene transmission. We found that chelerythrine (4 mg∙L−1) derived from Macleaya cordata extract, which is used as an animal feed additive, reduced the minimal inhibitory concentration (MIC) of colistin against an mcr-1 positive E. coli strain by 16-fold (from 2 to 0.125 mg∙L−1), eliminated approximately 104 colony-forming units (CFUs) of an mcr-1-carrying strain in a murine intestinal infection model, and inhibited the conjugation of an mcr-1-bearing plasmid in vitro (by >100-fold) and in a mouse model (by up to 5-fold). A detailed analysis revealed that chelerythrine binds to phospholipids on bacterial membranes and increases cytoplasmic membrane fluidity, thereby impairing respiration, disrupting proton motive force (PMF), generating reactive oxygen species (ROS), and decreasing intracellular adenosine triphosphate (ATP) levels, which subsequently downregulates mcr-1 and conjugation-associated genes. These dual effects of chelerythrine can expand the use of antibiotic adjuvants and may provide a new strategy for circumventing mobile colistin resistance.
Keywords: Chelerythrine Antibiotic adjuvant Conjugation inhibitor Colistinmcr-1 Dual effects
Title Author Date Type Operation
A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy
Xiaolong Wei,Chunfa Chen,Didi Xi,Jinwen Bai,Wenhe Huang,Luoxiang Rong,Mingyao Wu,Guojun Zhang
Journal Article
Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage
Journal Article
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma
Wei Zhang, Bixiang Zhang, Xiao-ping Chen
Journal Article
Deciphering the pharmacological mechanism of Guan-Jie-Kang in treating rat adjuvant-induced arthritis
Hudan Pan, Yanfang Zheng, Zhongqiu Liu, Zhongwen Yuan, Rutong Ren, Hua Zhou, Ying Xie, Liang Liu
Journal Article
Optimising the oil phases of aluminium hydrogel-stabilised emulsions for stable, safe and efficient vaccine adjuvant
Journal Article
Influence of the adjuvant therapy on the survival of patients with stage II pancreatic carcinoma
Xi-Yan WANG, Hai-Jun LI, Dong YAN, Hao WEN, Shu-Yong PENG,
Journal Article